Tuesday July 10, 2012 0 commentsAURORA - The Colorado Institute for Drug, Device and Diagnostic Development (CID4) today announced a collaboration with the Rockies Venture Club that's designed to leverage the organizations' complimentary assets and capabilities with a mission to accelerate high-quality, early-stage Colorado life science company financings.
The collaboration will benefit the state's life science companies and those who invest in them through shared resources and complimentary fundraising processes, the companies jointly said.
Peter Adams, Rockies Venture Club executive director, will bring his fundraising expertise to the CID4 Technical and Business Advisory Committee. Where appropriate, CID4 staff will work with RVC screening committees as technical advisors as part of the collaboration.
"We are very excited about this new collaboration," said Kevin M. Smith, president and CEO of CID4. "RVC has an impressive membership with the ability to provide foundational funding to early-stage companies. We look forward to expanding their investment universe to include the life sciences sector."
"The Rockies Venture Club has been working hard to develop early-stage funding in life sciences," said Adams. "Working with the team at CID4 brings tremendous knowledge, expertise and connections that not only help us to connect capital with promising life sciences companies, but also to provide assistance with due diligence, mentorship and support that helps ensure their ongoing success."
The Rockies Venture Club has been connecting entrepreneurs with angel investors, venture capitalists, service professionals and other business and funding resources since 1985.
For more information, visit http://www.rockiesventureclub.org.
Founded in 2009, the Colorado Institute for Drug, Device and Diagnostic Development - a 501 (c) (3) not-for-profit - has been working to advance the Colorado bioscience ecosystem through company creation and job growth.
For more information, visit http://CID4.com.